Global Health June 7, 2024 Engimmune Therapeutics, a world-class developer of soluble T-cell receptor (‘TCR’) drugs to treat solid tumours
Global Health May 31, 2024 Harnessing the Power of Data for Better Patient Outcomes and Exciting New Collaborations
